IRLAB Therapeutics AB
STO:IRLAB A

Watchlist Manager
IRLAB Therapeutics AB Logo
IRLAB Therapeutics AB
STO:IRLAB A
Watchlist
Price: 12.6 SEK -1.95% Market Closed
Market Cap: 652.5m SEK
Have any thoughts about
IRLAB Therapeutics AB?
Write Note

Operating Margin
IRLAB Therapeutics AB

-286.5%
Current
-630%
Average
6.8%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-286.5%
=
Operating Profit
-119.1m
/
Revenue
41.6m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
SE
IRLAB Therapeutics AB
STO:IRLAB A
653.5m SEK
-286%
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY
-83%
US
Eli Lilly and Co
NYSE:LLY
788.1B USD
35%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
DK
Novo Nordisk A/S
CSE:NOVO B
3.4T DKK
45%
US
Johnson & Johnson
NYSE:JNJ
384.8B USD
28%
US
Merck & Co Inc
NYSE:MRK
259.4B USD
29%
CH
Roche Holding AG
SIX:ROG
213.6B CHF
32%
UK
AstraZeneca PLC
LSE:AZN
171.2B GBP
21%
CH
Novartis AG
SIX:NOVN
183.5B CHF
29%
US
Pfizer Inc
NYSE:PFE
160.4B USD
22%
Country SE
Market Cap 653.5m SEK
Operating Margin
-286%
Country JP
Market Cap 776 550.9T JPY
Operating Margin
-83%
Country US
Market Cap 788.1B USD
Operating Margin
35%
Country UK
Market Cap 440.4B GBP
Operating Margin
3%
Country DK
Market Cap 3.4T DKK
Operating Margin
45%
Country US
Market Cap 384.8B USD
Operating Margin
28%
Country US
Market Cap 259.4B USD
Operating Margin
29%
Country CH
Market Cap 213.6B CHF
Operating Margin
32%
Country UK
Market Cap 171.2B GBP
Operating Margin
21%
Country CH
Market Cap 183.5B CHF
Operating Margin
29%
Country US
Market Cap 160.4B USD
Operating Margin
22%

Profitability Report

View the profitability report to see the full profitability analysis for IRLAB Therapeutics AB.

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-286.5%
=
Operating Profit
-119.1m
/
Revenue
41.6m
What is the Operating Margin of IRLAB Therapeutics AB?

Based on IRLAB Therapeutics AB's most recent financial statements, the company has Operating Margin of -286.5%.